A detailed history of Ashburton (Jersey) LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ashburton (Jersey) LTD holds 10,869 shares of MRK stock, worth $1.11 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
10,869
Previous 14,113 22.99%
Holding current value
$1.11 Million
Previous $1.45 Million 7.43%
% of portfolio
0.57%
Previous 0.73%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 30, 2024

SELL
$123.8 - $132.96 $401,607 - $431,322
-3,244 Reduced 22.99%
10,869 $1.35 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $78,240 - $85,144
-781 Reduced 5.53%
13,332 $1.45 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $41,775 - $45,461
417 Added 3.04%
14,113 $1.45 Million
Q2 2023

Jul 19, 2023

SELL
$108.61 - $118.38 $401,965 - $438,124
-3,701 Reduced 21.27%
13,696 $1.58 Million
Q1 2023

May 17, 2023

BUY
$102.94 - $114.86 $56,719 - $63,287
551 Added 3.27%
17,397 $1.85 Million
Q4 2022

Apr 26, 2023

BUY
$87.44 - $112.11 $3,235 - $4,148
37 Added 0.22%
16,846 $1.87 Million
Q3 2022

Apr 26, 2023

BUY
$84.53 - $94.96 $1.42 Million - $1.6 Million
16,809 New
16,809 $1.45 Million
Q2 2022

May 26, 2023

BUY
$83.49 - $94.64 $6,846 - $7,760
82 Added 0.51%
16,160 $1.47 Million
Q4 2021

May 26, 2023

SELL
$72.28 - $90.54 $95,337 - $119,422
-1,319 Reduced 7.58%
16,078 $1.23 Million
Q3 2021

May 26, 2023

BUY
$71.68 - $78.83 $8,314 - $9,144
116 Added 0.58%
20,273 $1.52 Million
Q2 2021

May 26, 2023

SELL
$70.31 - $77.77 $279,552 - $309,213
-3,976 Reduced 16.48%
20,157 $1.57 Million
Q1 2021

May 26, 2023

BUY
$68.86 - $81.11 $463,840 - $546,356
6,736 Added 38.72%
24,133 $1.77 Million
Q4 2020

May 23, 2023

BUY
$71.77 - $79.65 $9.83 Million - $10.9 Million
136,979 Added 787.37%
154,376 $12 Million
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $15 Million - $17.1 Million
-213,235 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $179,287 - $202,304
2,311 Added 1.1%
213,235 $19.4 Million
Q3 2019

Nov 15, 2019

BUY
$76.08 - $82.93 $57,060 - $62,197
750 Added 0.36%
210,924 $17.8 Million
Q2 2019

Jul 26, 2019

BUY
$69.84 - $81.59 $39,389 - $46,016
564 Added 0.27%
210,174 $17.6 Million
Q1 2019

May 20, 2019

SELL
$69.58 - $79.36 $1.35 Million - $1.54 Million
-19,453 Reduced 8.49%
209,610 $17.4 Million
Q4 2018

Feb 28, 2019

SELL
$65.24 - $75.71 $5.61 Million - $6.51 Million
-85,934 Reduced 27.28%
229,063 $17.5 Million
Q4 2018

Feb 04, 2019

BUY
$65.24 - $75.71 $2.83 Million - $3.28 Million
43,319 Added 15.94%
314,997 $19.1 Million
Q3 2018

Nov 05, 2018

SELL
$57.69 - $67.84 $2.5 Million - $2.94 Million
-43,319 Reduced 13.75%
271,678 $19.3 Million
Q2 2018

Sep 06, 2018

BUY
$50.83 - $59.72 $268,636 - $315,620
5,285 Added 1.71%
314,997 $19.1 Million
Q1 2018

May 25, 2018

BUY
$50.96 - $59.23 $15.8 Million - $18.3 Million
309,712 New
309,712 $16.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $259B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ashburton (Jersey) LTD Portfolio

Follow Ashburton (Jersey) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashburton (Jersey) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ashburton (Jersey) LTD with notifications on news.